02/26/2026
At the Ivy Center, we’re enrolling patients with relapsed or refractory primary central nervous system lymphoma in a clinical trial studying the anti-cancer activity of Emavusertib (CA-4948).
Learn more: https://bar.rw/4rF0UTm
☎️: 602-406-8605